// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























28841 Abstracts

Occurrence and impact of pain among patients living with hemophilia: An analysis from the patient reported outcomes, burdens and experiences (PROBE) study

D. Noone - European Association for Haemophilia and Allied Disorders (EAHAD) , 2018

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

N/A

N/A

SPK‐9001: Adeno‐associated virus mediated gene transfer for hemophilia B—sustained fix activity and persistent prophylactic benefit at 1 year

L. A. George - European Association for Haemophilia and Allied Disorders (EAHAD) , 2018

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

N/A

N/A

PATH-48. THE DNA METHYLATION LANDSCAPE OF CORE AND PERIPHERAL DIFFUSE GLIOMA REGIONS SHOWS LITTLE SPATIAL SUBTYPE HETEROGENEITY AFTER CONSIDERING TUMOR PURITY

Jan Heijmans - Society for Neuro-Oncology (SNO) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Gliomas

N/A

ACTR-27. EVOLUTION OF THE NEUROSURGEON’S ROLE IN CLINICAL TRIALS FOR GBM: A SYSTEMATIC OVERVIEW OF THE CLINICALTRIALS.GOV DATABASE

Alireza Mansouri - Society for Neuro-Oncology (SNO) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Comparative assessment of the performance of pharmacokinetic tools for prophylactic dosing of factor VIII concentrate in patients with hemophilia A

P. Staibano - European Association for Haemophilia and Allied Disorders (EAHAD) , 2018

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

N/A

FVIII

Assessment of clotting activity of recombinant fix FC fusion protein in European hemophilia treatment centers

A. Willemze - European Association for Haemophilia and Allied Disorders (EAHAD) , 2018

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

N/A

Alprolix Intravenous

RARE-45. ACTIVITY OF LAROTRECTINIB IN TRK FUSION CANCER PATIENTS WITH PRIMARY CENTRAL NERVOUS SYSTEM TUMORS

Sebastien Perreault - Society for Neuro-Oncology (SNO) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Solid malignancies

Larotrectinib

High compliance to prophylaxis regimens in adult and paediatric hemophilia B patients receiving RIX‐FP in clinical studies

C. Altisent - European Association for Haemophilia and Allied Disorders (EAHAD) , 2018

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

N/A

N/A

Nonacog beta pegol (N9‐GP) for prophylaxis in children with hemophilia B: up to 3.5‐year data from the paradigm™5 clinical trial

E. Santagostino - European Association for Haemophilia and Allied Disorders (EAHAD) , 2018

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

N/A

N/A

ACTR-28. A CALL FOR INCREASED ROLE OF NEUROSURGEONS IN SURGICAL TRIALS FOR NON-GLIOMATOUS PRIMARY CNS TUMORS: A SYSTEMATIC REVIEW OF THE CLINICALTRIALS.GOV DATABASE

Alireza Mansouri - Society for Neuro-Oncology (SNO) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Pituitary adenomas

N/A

EPID-31. EFFICIENT STUDY OF SURGICALLY TREATED MENINGIOMA THROUGH CLINICAL DATA STANDARDIZATION

Yueren Zhou - Society for Neuro-Oncology (SNO) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Meningiomas

N/A

Beyond ABR: high fix activity translates into clinical benefits

G. Young - European Association for Haemophilia and Allied Disorders (EAHAD) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

EPID-15. GUIDELINES FOR THE OPTIMAL USE OF SOCIAL MEDIA FOR NEURO-ONCOLOGISTS

Nima Hamidi - Society for Neuro-Oncology (SNO) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Brain cancer

N/A

GENE-45. DISSECTING THE DRIVERS OF ADULT H3K27M-GLIOMAS AT THE SINGLE-CELL LEVEL

Ilon Liu - Society for Neuro-Oncology (SNO) , 2019

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

High-Grade Gliomas

methionine

Online course of pharmacokinetic monitoring in hemophilia with application in the clinical practice

S. Bonanad - European Association for Haemophilia and Allied Disorders (EAHAD) , 2018

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

N/A

N/A

The fibres study: a phase 3, non‐inferiority, randomized comparison of a new fibrinogen concentrate vs. cryoprecipitate for treating acquired hypofibrinogenemia in bleeding cardiac surgical patients

K. Karkouti - European Association for Haemophilia and Allied Disorders (EAHAD) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Fibrinogen (IV)

PDCT-08. SUPERIOR OUTCOME FOR BRAF V600E PEDIATRIC GLIOMAS TREATED WITH TARGETED BRAF INHIBITION

Murali Chintagumpala - Society for Neuro-Oncology (SNO) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Gliomas

N/A

Does blood group 0 influence inhibitor development? Data from the pednet registry

M. Van Den Berg - European Association for Haemophilia and Allied Disorders (EAHAD) , 2018

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

N/A

N/A

HOUT-23. ADULT MEDULLOBLASTOMA TREATMENT IMPACT SINCE 2006: A CANADIAN UNIVERSITY CENTER EXPERIENCE

France Berthelet - Society for Neuro-Oncology (SNO) , 2019

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Medulloblastoma

N/A

CSIG-26. IS INTRINSIC APOPTOSIS THE SIGNALING PATHWAY ACTIVATED BY TUMOR-TREATING FIELDS FOR GLIOBLASTOMA?

Kristen Carlson - Society for Neuro-Oncology (SNO) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Glioblastoma

Dexamethasone

Copyright © 2026. QuantiNova All rights reserved